SCHEMBL18954857

SCHEMBL18954857

O=C(O)CCN1C(=O)C(=O)c2cc(S(=O)(=O)[O-])ccc21.[Na+]

nearest known ligand 0.54

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CA12 known ✓ O43570 7/20 0.50
▸ CA1 known ✓ P00915 7/20 0.50
▸ CA2 known ✓ P00918 7/20 0.50
▸ CASP3 P42574 3/20 0.54
▸ CASP7 P55210 3/20 0.54
▸ CA9 Q16790 7/20 0.50
▸ PARK7 Q99497 2/20 0.45
▸ NSD2 O96028 1/20 0.44
▸ CASP6 P55212 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ ALDH2 P05091 1/20 0.41
▸ ALDH3A1 P30838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954750 0.92 CA12 (0.48) CASP3CASP7CA12CA1CA2
SCHEMBL18954856 0.86 CASP3 (0.57) CASP3CASP7CA12CA1CA2
SCHEMBL18954663 0.86 CASP3 (0.50) CASP3CASP7CA12CA1CA2
SCHEMBL18955305 0.83 ALDH1A1 (0.55) CASP3CASP7CA12CA1CA2
SCHEMBL18954748 0.79 CASP3 (0.50) CASP3CASP7CA12CA1CA2
SCHEMBL18955347 0.78 ALDH1A1 (0.53) CASP3CASP7CASP6ALDH1A1
SCHEMBL18954687 0.77 CA1 (0.57) CASP3CASP7CA12CA1CA2
SCHEMBL18954656 0.76 CASP3 (0.47) CASP3CASP7PARK7ALDH1A1ALDH2
SCHEMBL18954660 0.76 CASP3 (0.57) CASP3CASP7PARK7ALDH1A1ALDH2
SCHEMBL1519990 0.75 CES1 (0.71) PARK7ALDH1A1ALDH2ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback